Rafael Holdings is a pharmaceutical and biotechnology company that focuses on developing drugs and holding strategic interests in clinical-stage companies. Its primary developmental focus centers on pharmaceutical candidates targeting rare genetic disorders and specialized medical conditions through advanced clinical trials, alongside maintaining legacy real estate asset holdings.